Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-08 12:00 pm Sale | 2021-12-31 | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 0 0.000% | -8,500,000 (Position Closed) | Filing History |
| 2021-02-12 6:42 pm Purchase | 2020-12-31 | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 8,500,000 9.800% | 250,000 (+3.03%) | Filing History |
| 2020-06-23 10:26 am Sale | 2020-06-19 | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Lantheus Holdings Inc. LNTH | 1,000 100.000% | -8,010,733 (-99.99%) | Filing History |
| 2020-06-04 4:06 pm Sale | 2020-06-01 | 13G | PROGENICS PHARMACEUTICALS INC PGNX | EAGLE ASSET MANAGEMENT INC | 31 5.000% | -4,506,253 (-100.00%) | Filing History |
| 2020-04-23 5:00 pm Purchase | 2020-04-14 | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Lantheus Holdings Inc. LNTH | 8,011,733 9.300% | 8,011,733 (New Position) | Filing History |
| 2020-04-15 3:15 pm Unchanged | 2020-04-14 | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Altiva Management Inc. | 8,011,733 9.300% | 0 (Unchanged) | Filing History |
| 2020-04-09 4:49 pm Unchanged | 2020-04-03 | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Altiva Management Inc. | 8,011,733 9.300% | 0 (Unchanged) | Filing History |